Alefacept

In the US, Alefacept (alefacept systemic) is a member of the drug class selective immunosuppressants and is used to treat Psoriasis.

US matches:

• Alefacept


• Alefacept; water, sterile Intramuscular, Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA15

CAS registry number (Chemical Abstracts Service)

0222535-22-0

Chemical Formula

C3264-H5002-N840-O988-S20

Molecular Weight

72740

Therapeutic Categories

Selective immunosuppressant

Antipsoriatic

Chemical Name

1-92-antigen LFA-3 (human) fusion protein with human immunoglobulin G1 (hinge-CH2-CH3 gamma1-chain), dimer (WHO)

Foreign Names

• Alefaceptum (Latin)
• Alefacept (German)
• Aléfacept (French)
• Alefacept (Spanish)

Generic Names

• Alefacept (OS: USAN, BAN)
• BG 9273 (IS: Biogen)
• BG 9712 (IS: Biogen)
• Human LFA 3IgG fusion protein (IS)
• Leukocyte function-associated antigen-3 (IS)
• LFA 3 (IS)
• LFA 3CD2 (IS)
• LFA 3TIP (IS: Biogen)
• LFA-(92)IgG (IS)
• Recombinant LFA-3/IgG1 fusion protein (IS)

Brand Names

• Amevive
  Astellas, Canada; Biogen, United States

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.